MedPath

Serum Hs-CRP in Periodontitis Patients With or Without Diabetes

Not Applicable
Completed
Conditions
Periodontal Disease
Diabetes Mellitus, Type 2
Interventions
Procedure: Scaling and root planing
Registration Number
NCT03908606
Lead Sponsor
Cairo University
Brief Summary

the aim of this study was to assess serum levels of high sensitivity c reactive protein in periodontitis patients with and without type 2 diabetes in a trial to analyze its prognostic effect following non-surgical periodontal therapy.

Detailed Description

Periodontitis and diabetes are chronic disorders with a two-way correlation as they can both stimulate an inflammatory response with subsequent formation of inflammatory mediators and cytokines. C reactive protein is an inflammatory plasma marker having a role in the systemic reaction to inflammation. thus, our aim in the current study was to evaluate serum levels of high sensitivity c reactive protein in periodontitis patients with and without type 2 diabetes in a trial to analyze its prognostic effect following non-surgical periodontal therapy. A total of 60 patients were enrolled in this study. ELISA was used for determination of hs- CRP. Non- surgical periodontal therapy was carried out for all periodontitis patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Diabetic patients type 2
  2. Periodontitis patients
Exclusion Criteria
  1. Smokers
  2. Pregnant females

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Periodontitis patients with diabetes type 2Scaling and root planingscaling and root planing was administered to all patients. Serum samples were collected before and after treatment to assess hs-CRP levels. Glycated hemoglobin was measured before and after treatment
Periodontitis patientsScaling and root planingscaling and root planing will be done to periodontitis patients. Serum samples were collected before and after treatment to assess hs-CRP levels.
Primary Outcome Measures
NameTimeMethod
clinical attachment level3 months

gain in clinical attachment level

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Cairo University

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath